Compare PNC & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PNC | ELV |
|---|---|---|
| Founded | 1852 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.2B | 96.6B |
| IPO Year | 2010 | 2001 |
| Metric | PNC | ELV |
|---|---|---|
| Price | $231.65 | $428.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 22 |
| Target Price | $263.57 | ★ $482.38 |
| AVG Volume (30 Days) | ★ 1.8M | 1.3M |
| Earning Date | 10-15-2026 | 10-21-2026 |
| Dividend Yield | ★ 3.46% | 1.60% |
| EPS Growth | ★ 20.74 | N/A |
| EPS | 13.91 | ★ 21.01 |
| Revenue | $23,099,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $14.20 | N/A |
| Revenue Next Year | $5.78 | $2.46 |
| P/E Ratio | ★ $16.63 | $20.47 |
| Revenue Growth | 7.16 | ★ 12.49 |
| 52 Week Low | $177.08 | $274.89 |
| 52 Week High | $258.96 | $450.69 |
| Indicator | PNC | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 54.08 |
| Support Level | $224.36 | $373.93 |
| Resistance Level | $241.12 | $430.13 |
| Average True Range (ATR) | 4.95 | 12.99 |
| MACD | 0.64 | -0.38 |
| Stochastic Oscillator | 48.26 | 52.93 |
PNC Financial is one of the three super-regional banks in the US, with over $600 billion in total assets at the end of June 2026. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It closed its acquisition of FirstBank in January 2026, which added around $26 billion in assets to its balance sheet, and PNC is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 38% of revenue from fee income and 62% from net interest income in 2025.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.